Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP802824.RAX9A_rGhA9mNJMDhzDpC5qglCaKEt3JT2xPoCjkODX4U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP802824.RAX9A_rGhA9mNJMDhzDpC5qglCaKEt3JT2xPoCjkODX4U130_assertion type Assertion NP802824.RAX9A_rGhA9mNJMDhzDpC5qglCaKEt3JT2xPoCjkODX4U130_head.
- NP802824.RAX9A_rGhA9mNJMDhzDpC5qglCaKEt3JT2xPoCjkODX4U130_assertion description "[The combined inhibition of EGFR and MET receptor could represent a strategy for preventing and/or overcoming cetuximab resistance in patients with colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP802824.RAX9A_rGhA9mNJMDhzDpC5qglCaKEt3JT2xPoCjkODX4U130_provenance.
- NP802824.RAX9A_rGhA9mNJMDhzDpC5qglCaKEt3JT2xPoCjkODX4U130_assertion evidence source_evidence_literature NP802824.RAX9A_rGhA9mNJMDhzDpC5qglCaKEt3JT2xPoCjkODX4U130_provenance.
- NP802824.RAX9A_rGhA9mNJMDhzDpC5qglCaKEt3JT2xPoCjkODX4U130_assertion SIO_000772 24122793 NP802824.RAX9A_rGhA9mNJMDhzDpC5qglCaKEt3JT2xPoCjkODX4U130_provenance.
- NP802824.RAX9A_rGhA9mNJMDhzDpC5qglCaKEt3JT2xPoCjkODX4U130_assertion wasDerivedFrom befree-20150227 NP802824.RAX9A_rGhA9mNJMDhzDpC5qglCaKEt3JT2xPoCjkODX4U130_provenance.
- NP802824.RAX9A_rGhA9mNJMDhzDpC5qglCaKEt3JT2xPoCjkODX4U130_assertion wasGeneratedBy ECO_0000203 NP802824.RAX9A_rGhA9mNJMDhzDpC5qglCaKEt3JT2xPoCjkODX4U130_provenance.